Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Announces Exchange Offer for Its 2 1/2 Percent Contingent Convertible Subordinated Notes Due 2008
Integra LifeSciences Announces Exchange Offer for Its 2 1/2 Percent Contingent Convertible Subordinated Notes Due 2008 PLAINSBORO, N.J., Jul 17, 2006 (PRIMEZONE via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has commenced an offer to
View HTML
Toggle Summary Integra LifeSciences Announces Direct Sales Strategy in Canada
Integra LifeSciences Announces Direct Sales Strategy in Canada Acquires Canada Microsurgical Ltd. PLAINSBORO, N.J., July 11, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it is launching a direct sales force in Canada through the acquisition of its
View HTML
Toggle Summary Integra LifeSciences Announces Determination of Entitlement to Contingent Interest On Convertible Notes Due 2008
PLAINSBORO, N.J., Feb 20, 2008 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has determined that holders of its 2 1/2% Contingent Convertible Subordinated Notes due 2008 ("Notes") shall be entitled to receive contingent
View HTML
Toggle Summary Integra LifeSciences Announces Definitive Agreement to Sell Certain Neurosurgery Assets to Natus Medical Incorporated
Natus Medical to acquire global Camino® ICP monitoring product line, U.S. rights to Integra's fixed pressure shunts, and U.S. rights to Codman's DURAFORM®, EVD catheters and CSF collection systems Integra is providing a preliminary estimate for a fourth quarter 2017 revenue contribution of
View HTML
Toggle Summary Integra LifeSciences Announces Definitive Agreement to Divest its Extremity Orthopedics Business to Smith+Nephew for $240 Million
PRINCETON, N.J., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has entered into a definitive agreement to sell its Extremity Orthopedics business to Smith+Nephew (LSE:SN, NYSE:SNN) for $240
View HTML
Toggle Summary Integra LifeSciences Announces Definitive Agreement to Acquire Surgical Innovation Associates (SIA) and Plans for $150 Million Share Repurchase
Acquisition will add distinct new product solution for plastic and reconstructive surgery to address clinical needs and improve patient outcomes Deploys capital to support strong profitable growth and greater returns for our shareholders PRINCETON, N.J., Dec.
View HTML
Toggle Summary Integra LifeSciences Announces Definitive Agreement to Acquire ACell, Inc.
Adds proprietary technology platform and complementary products to grow Integra’s regenerative portfolio PRINCETON, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) a leading global medical technology company, today announced it has entered into a
View HTML
Toggle Summary Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®
The acquisition will become part of Integra’s Codman Specialty Surgical (CSS) division. The ear, nose and throat (ENT) category is a key area of strategic interest and highly complementary to the neurosurgery segment. Provides a unique opportunity to build scale and capture a leadership position in
View HTML
Toggle Summary Integra LifeSciences Announces CUSA Ultrasonic Aspirator Distribution Agreement With AMCO, Inc. for Japan
PLAINSBORO, N.J., May 24, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) announced today that it has signed a five-year contract with AMCO, Inc. to promote and sell the CUSA(R) Excel ultrasonic surgical aspirator family of products in Japan.
View HTML
Toggle Summary Integra LifeSciences Announces Creation of Medical Instrument Selling Organization, Formation of Integra Pain Management, and Elimination of Bimeco Operations
PLAINSBORO, N.J., Jul 13, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the formation of its Medical Instrument selling organization. The Medical Instrument selling organization consists of Miltex(R) instruments, Jarit(R)
View HTML
Toggle Summary Integra LifeSciences Announces Contract with Premier, Inc.
Will Provide Small Bone Orthopedic Implants
View HTML
Toggle Summary Integra LifeSciences Announces Contract With Premier Purchasing Partners
Integra LifeSciences Announces Contract With Premier Purchasing Partners PLAINSBORO, N.J., Feb. 27, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) announced today that its Jarit Surgical Instruments subsidiary has signed a three-year contract to supply Jarit®
View HTML
Toggle Summary Integra LifeSciences Announces Contract With Premier Purchasing Partners
PLAINSBORO, N.J., Dec. 7, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has signed a three-year contract for Luxtec(R) surgical headlights, light sources and accessories with Premier Purchasing Partners, LLP (Premier), the group purchasing
View HTML
Toggle Summary Integra LifeSciences Announces Contract With Novation
PLAINSBORO, N.J., Sep 24, 2008 (GlobeNewswire via COMTEX News Network) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) announced today that Integra OrthoBiologics has signed a three-year contract with Novation, one of the industry's leading contracting services companies, to supply
View HTML
Toggle Summary Integra LifeSciences Announces Contract With MedAssets Supply Chain Systems, LLC.
PLAINSBORO, N.J., May 23, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) announced today that its Jarit Surgical Instruments subsidiary has signed a three-year contract to supply Jarit(R) surgical and laparoscopic instruments to members of
View HTML